Search company, investor...

PrimeraDX

primeradx.com

Founded Year

2004

Stage

Debt | Alive

Total Raised

$53.15M

Last Raised

$1.15M | 13 yrs ago

About PrimeraDX

PrimeraDx, formerly Primera Biosystems, is developing a platform and companion assays for quantitative multiplex molecular diagnostics that aims to enable improved patient management and reduced overall healthcare costs in the areas of infectious disease and oncology. Primera's assays and instrument systems are based on the company's STAR "Scalable Target Analysis Routine" technology, which aims to enable simultaneous quantitative measurement of up to 60 genes in a single assay by real-time PCR with appropriate sensitivity, accuracy and specificity.

Headquarters Location

171 Forbes Boulavard Suite 2000

Mansfield, Massachusetts, 02048,

United States

508-618-2300

Missing: PrimeraDX's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PrimeraDX's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing PrimeraDX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PrimeraDX is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

PrimeraDX Patents

PrimeraDX has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/13/2014

6/28/2016

Molecular biology, MicroRNA, Biotechnology, MicroRNA precursor families, DNA

Grant

Application Date

1/13/2014

Grant Date

6/28/2016

Title

Related Topics

Molecular biology, MicroRNA, Biotechnology, MicroRNA precursor families, DNA

Status

Grant

Latest PrimeraDX News

PrimeraDx Inc. Medical Equipment Deals and Alliances Profile Prices from USD $250

Feb 2, 2017

PrimeraDx, Inc. Medical Equipment Deals and Alliances Profile Prices from USD $250 16:24 EST 2 Feb 2017 | BioPortfolio Reports Home » Topics » Molecular diagnostics » Latest News » PrimeraDx, Inc. Medical Equipment Deals and Alliances Profile Prices from USD $250 Summary PrimeraDx Inc Primera, formerly PRIMERA BIOSYSTEMS, INC, a subsidiary of QIAGEN Mansfield, Inc., is a molecular diagnostic company that develops and delivers products for advance patient care. The company's product includes Modaplex System. Its Modaplex System is an open platform that allows clinical researchers to detect and quantify mRNA, miRNA , pathogens, methylation status, fusion genes, copy number variation and SNPs. Primera offers consumable products such as cartridge, CE plate, mineral oil, CE gel, modaplex buffer, modaplex decon, PCR plate and modaplex wash. The company's products are applicable in the field of oncology, infectious disease, translational medicine research and pharma QC. Primera is headquartered in Mansfield, Massachusetts, the US. PrimeraDx, Inc. Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

PrimeraDX Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PrimeraDX Rank

PrimeraDX Frequently Asked Questions (FAQ)

  • When was PrimeraDX founded?

    PrimeraDX was founded in 2004.

  • Where is PrimeraDX's headquarters?

    PrimeraDX's headquarters is located at 171 Forbes Boulavard, Mansfield.

  • What is PrimeraDX's latest funding round?

    PrimeraDX's latest funding round is Debt.

  • How much did PrimeraDX raise?

    PrimeraDX raised a total of $53.15M.

  • Who are the investors of PrimeraDX?

    Investors of PrimeraDX include MPM Capital, Malaysian Technology Development Corporation, Burrill & Company, InterWest Partners, Invus Group and 5 more.

  • Who are PrimeraDX's competitors?

    Competitors of PrimeraDX include Quanterix, Sword Diagnostics, CytoBioscience, Sequenom, Cavadis and 10 more.

Compare PrimeraDX to Competitors

M
Motia

Primera BioSystems, formerly known as Sention, is developing gene expression analysis assays and instruments for use in research and diagnostic laboratories. The underlying STAR technology (Scalable Trancriptional Analysis Routine) aims to enable combining multiplexing (<20 genes) and real time PCR in a single assay.

P
Proteopure

Proteomics is widely viewed as the cornerstone of future success in drug discovery and clinical diagnostics, but the complexity of protein molecules and their interactions requires new tools to find and understand biomarkers and protein functions. A critical step in the research process is to properly prepare the molecular sample before analysis can begin. Proteopure, Inc.'s technology is the foundation of a simple laboratory "kit" that fills unmet research needs.nProteopure developed and is now marketing sample protein preparation kits. In addition, Proteopure markets complementary products where there is overlapping customer synergy. These other products include a kit for membrane sample preparation, a kit for measuring protein concentration, fluorescent nanoclusters and beads for labeling proteins, and fluorescent tagged genes for measuring protein expression and location.

S
Sword Diagnostics

Sword Diagnostics is a life sciences company created in response to the needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable to effectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays. Sword's mission is to provide the next-generation detection technology to life scientists, enabling them to continue advances in medical research, drug discovery and the provision of health care products and services.

Fluxion Biosciences Logo
Fluxion Biosciences

Fluxion Biosciences is a developer of precision solutions for life science research and diagnostics. Fluxion's liquid biopsy solutions are changing how cancer is detected and treated. Fluxion's pioneering liquid biopsy technologies include the IsoFlux CTC Liquid Biopsy System, ERASE-Seq ultra-sensitive variant caller, and the Spotlight 59 NGS Oncology Panel for cancer mutation detection from cell-free circulating tumor DNA. Fluxion's technologies are used globally by cancer centers developing new tests for early cancer detection and patient monitoring.

G
Genomic Solutions

The scientists at Genomic Solutions have a wealth of genomic, protein analysis and nano-liter dispensing application-based expertise that they would like to share with users. First select their area of research, followed by interest and then application, and finally, to the company's instrumentation which can help facilitate their research. Whether users are involved in the life science or biotechnology research community, the company's products will enable users to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. You achieve rapid and less expensive drug discovery.

S
SLIM Search

SLIM Search aims to offer scalable, fast, real time genomic analysis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.